Related Experiment Video
Updated: May 11, 2026

06:02
Multi-timescale Microscopy Methods for the Characterization of Fluorescently-labeled Microbubbles for Ultrasound-Triggered Drug Release
Published on: June 12, 2021
Renal interstitial permeability changes induced by microbubble-enhanced diagnostic ultrasound
Peijing Li1, Yunhua Gao, Jihang Zhang
1Xinqiao Hospital, The Third Military Medical University, Chongqing, China.
Journal of Drug Targeting
|May 1, 2013
Summary
Ultrasound-targeted microbubble destruction (UTMD) enhances kidney interstitial permeability reversibly without affecting glomeruli. This technique shows promise for targeted drug delivery in kidney diseases.
Area of Science:
- Nephrology
- Biomedical Engineering
- Pharmacology
Background:
- Ultrasound-targeted microbubble destruction (UTMD) is explored for enhancing glomerular permeability for drug delivery in kidney diseases.
- The impact of UTMD on renal interstitial permeability remains less understood.
Purpose of the Study:
- To investigate the effect of UTMD on renal interstitial permeability.
- To evaluate the safety and reversibility of UTMD-induced permeability changes in the kidney.
Main Methods:
- Diagnostic ultrasound (DUS) with microbubbles (MBs) was used to insonate the left kidney of Sprague-Dawley rats.
- Renal vascular permeability was assessed using Evans blue (EB) dye.
- Kidney tissue was examined using hematoxylin and eosin (HE) staining and electron microscopy.
- Localization and retention of fluorescently labeled MBs were tracked.
- Urinalysis was performed to detect proteinuria.
Main Results:
- Both continuous and intermittent UTMD modes increased renal vascular permeability, which recovered within 24 hours.
- Intermittent UTMD caused more significant injury than continuous mode.
- Red blood cells leaked into the interstitium, but glomerular capillary hemorrhage was absent.
- Electron microscopy confirmed reversible disruption of interstitial capillary walls.
- Fluorescent MBs localized primarily in the renal interstitium and were retained for 24 hours.
- No clinical proteinuria was observed post-treatment.
Conclusions:
- Microbubble plus diagnostic ultrasound specifically and reversibly enhances renal interstitial permeability.
- This approach does not affect the glomerulus, suggesting potential for targeted drug delivery to specific kidney compartments.
- UTMD offers a potential therapeutic strategy for localized drug delivery in treating kidney diseases.

